Added to YB: 2024-10-16
Pitch date: 2024-10-16
VRTX:US [bullish]
Vertex Pharmaceuticals Incorporated
+3.83%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.
Market Cap
$132.1B
Pitch Price
$490.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.32
P/E
30.33
EV/Sales
9.57
Sector
Biotechnology
Category
N/A
Show full summary:
Vertex Pharmaceuticals Incorporated VRTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)